Displaying items by tag: department of pathology

Elizabeth Brown, Ph.D., has received a $3.1 million grant from the National Cancer Institute to study epigenetic contribution to the excess risk of a precursor of multiple myeloma in African Americans.
Blood shortages are common in the summer months, and COVID-19 has played havoc with usual donation patterns.
The lab’s clinical expertise combined with the powerful diagnostic capability of its instruments will allow UAB to offer patients increasingly targeted, personalized treatment.
Using spatial transcriptomics, UAB researchers set out to understand the differences and similarities between two viral infections causing acute lung injury, as it could improve patient care, as well as identify novel therapeutic targets.
UAB will now operate three community vaccination sites — two downtown and one in Hoover — in an effort to distribute the COVID-19 vaccine to more people.
“These vaccines are our way out of the epidemic, and we want to do all we can to help get Alabama out of this as quickly as possible,” said Sarah Nafziger, M.D.
Altered epigenetic marks on ribosomal RNAs appear to create a pool of specialized ribosomes that can differentially regulate translation of specific messenger RNA.
The COVID-19 pandemic has disrupted normal blood donation patterns, leaving the nation’s blood supply perilously low.
Page 4 of 10